Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 04, 2015 4:35 PM ET


Company Overview of Barrier Therapeutics, Inc.

Company Overview

Barrier Therapeutics, Inc. develops and commercializes pharmaceutical products in the field of dermatology. It markets Xolegel, a topical gel for the treatment of seborrheic dermatitis; Vusion, a topical ointment for the treatment of infants and children with diaper dermatitis; and Solage, a topical solution for the treatment of solar lentigines. The company’s product pipeline includes Hyphanox in Phase III clinical trial for the treatment of onychomycosis; Pramiconazole in Phase IIa clinical trial for the treatment of onychomycosis, and skin and mucosal fungal infections; and Oral Rambazole in Phase IIb clinical trial for the treatment of psoriasis. Its pipeline portfolio also consists of T...

600 College Road East

Suite 3200

Princeton, NJ 08540-6636

United States

Founded in 2001

128 Employees





Key Executives for Barrier Therapeutics, Inc.

Secretary and General Counsel
Age: 45
Compensation as of Fiscal Year 2015.

Similar Private Companies By Industry

Company Name Region
Aires Pharmaceuticals, Inc. United States
Erimos Pharmaceuticals, LLC United States
BPR Health International, Inc. United States
Novasan, LLC United States
Neuraltus Pharmaceuticals, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Barrier Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at